Redox Environment and its Meaning for Breast Cancer Cells Fate
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
479-495
Author(s):
E. A. Ostrakhovitch
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
625-633
Author(s):
Robert W. Robey, Paul R. Massey, Laleh Amiri-Kordestani and Susan E. Bates
Nitrogen-Containing Bisphosphonates and Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3007-3014
Author(s):
P. Clezardin and M. Massaia
Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
816-821
Author(s):
Annika Bundscherer, Albrecht Reichle, Christian Hafner, Stefanie Meyer and Thomas Vogt
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
32-71
Author(s):
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento
Suramin: Clinical Uses and Structure-Activity Relationships
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
8
Page:
1384-1394
Author(s):
Ross P. McGeary, Andrew J. Bennett, Quoc B. Tran, Kelly L. Cosgrove and Benjamin P. Ross
Steroid Biosynthesis Inhibitors in the Therapy of Hypercortisolism: Theory and Practice
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
2734-2747
Author(s):
P. Igaz, Z. Tombol, P. M. Szabo, I. Liko and K. Racz
Potential Benefits of Glitazones for Cancer and Vascular Disease
Journal:
Current Drug Therapy
Volume:
3
Page:
111-125
Author(s):
Jose M. Perez-Ortiz, Silvia Llorens, Juan Llopis, Pedro A. Tranque and Eduardo Nava
Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3400-3416
Author(s):
Haruyo Ichikawa, Yutaka Nakamura, Yoshiki Kashiwada and Bharat B. Aggarwal
Subject Index To Volume 6
Journal:
Current Molecular Medicine
Volume:
7
Page:
v-xv
Author(s):